49
Participants
Start Date
August 31, 2004
Primary Completion Date
June 30, 2011
Study Completion Date
February 29, 2012
GW572016
Lapatinib, 500 mg
lapatinib
Lapatinib 500 mg PO
Baylor Breast Center, Houston
University of New Mexico, Albuquerque
USC Norris Comprehensive Cancer Center, Los Angeles
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Baylor Breast Care Center
OTHER